Beam Therapeutics News and Activities

Presence

Beam Therapeutics develops genetic medicines for serious diseases. Its products and services include gene editing therapies, research programs, and drug development for patients, healthcare providers, and pharmaceutical partners.

Beam Therapeutics products and services overview:

  • Gene editing therapies
  • Cell therapies
  • Research services
  • Drug discovery
  • Clinical development
  • Rare disease treatments

Revenue: ~$67 million

Employees: 500

Headquarters: Cambridge, United States (USA)


Beam Therapeutics is one of the...

Beam Therapeutics is a company listed under the stock ticker BEAM (US).

Executives

View the org chart displaying its 31 main executives

Most searched biographies at Beam Therapeutics

Create your alert
to follow the executive moves at Beam Therapeutics.

Biotechnology

Beam Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Beam Therapeutics
Social media about Beam Therapeutics

Get in Touch

Call Beam Therapeutics at +1 610...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board